Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 331 across all filing types
Latest filing 2024-09-17 Earnings Release
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Contract Award
Earnings Release Classification · 1% confidence The document is identified by the header 'RNS Number : 3146E' and concludes with information about RNS, the news service of the London Stock Exchange. The content announces a 'Contract Award' by Physiomics plc to an existing client, detailing the value (£65k) and scope. This is a typical corporate announcement made via the Regulatory News Service (RNS). Since it is a specific announcement that doesn't fit the definitions for ER, DIV, DIRS, or CAP, and it is not a report itself (like 10-K or IR), the most appropriate classification is the general regulatory announcement category, RNS. FY 2024
2024-09-17 English
Result of WRAP Retail Offer
Capital/Financing Update Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the completion of a capital raise ('WRAP Retail Offer') and the subsequent issue of new Ordinary Shares, raising gross proceeds of £406,417. This relates directly to fundraising and capital structure changes. While it announces a capital event (CAP), the primary nature of the filing itself, being a general regulatory announcement distributed via RNS, makes 'RNS' a strong candidate, especially given the short length (4289 chars) and the fact that it is an announcement rather than a comprehensive financial report. However, since the core subject matter is clearly about raising capital ('Fundraise', 'issue of new Ordinary Shares'), the 'Capital/Financing Update' (CAP) classification is more specific to the content than the general 'RNS' fallback. Given the explicit mention of share issuance and fundraising, CAP is the most accurate content classification.
2024-07-05 English
Completion of Placing & WRAP Retail Offer Launch
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Physiomics PLC regarding a completed share placing and the launch of a retail offer to raise capital. It details the number of shares, the issue price, the purpose of the funds, and the regulatory context (AIM market). This falls under the category of capital raising and financing activities.
2024-07-03 English
WRAP Retail Offer for up to £25,000
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement (indicated by 'RNS Number : 8797U') from Physiomics PLC, dated July 3, 2024. The content explicitly announces a 'WRAP Retail Offer' and a 'Placing' to raise capital (£25,000 and £381,417 respectively) through the issue of new ordinary shares. This clearly falls under the category of company fundraising and capital structure changes. The most specific code for this activity is 'CAP' (Capital/Financing Update). Although it is distributed via RNS, the core subject matter is capital raising, making CAP the primary classification over the general regulatory filing code RNS.
2024-07-03 English
DoseMe Precision Dosing - Modeling & Functionality
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 4783S' and contains a press release format announcing a business development: 'Physiomics Adds Modeling and Data Science Functionality to DoseMe's Precision Dosing Platform'. It includes company commentary, background information, and contact details, typical of a general corporate announcement distributed via the Regulatory News Service (RNS). Since it is a specific business update that doesn't fit perfectly into categories like ER, 10-K, or DIV, and it is clearly a formal announcement distributed through the RNS system, the most appropriate classification is the general regulatory announcement fallback, RNS.
2024-06-14 English
Contract Award
Regulatory Filings Classification · 1% confidence The document is very short (3282 characters) and announces a specific corporate event: a 'Contract Award' worth £186k. It is distributed via 'RNS Number' and mentions the 'London Stock Exchange' and 'Financial Conduct Authority', indicating it is a regulatory announcement. Since the content is a specific operational update (contract win) and not a standard financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, SHA, DIRS), it falls best under the general regulatory announcement category, which is RNS. It is not an announcement *about* a report, but the report itself (a news release).
2024-06-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.